motherlodetv.net
A deep analysis on a strong company is always invaluable information for any junior mining investor, whether independent or professional, and the initial investment report by Eight Capital on White Gold Corp is no exception.
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma”) and Solarvest BioEnergy Inc. (TSX-V: SVS) (“Solarvest”) (collectively, the “Parties”), are pleased to announce that, further to their press release of May 7, 2019, the Parties have agreed to amendments to the Collaborative Research and Development Agreement (the “Research Agreement”) designed to accelerate progress of the research project that Solarvest is carrying out (the “CBD Research Project”). Under the amended Research Agreement, FSD Pharma has agreed to issue additional class B subordinate voting shares (“FSD Shares”) to Solarvest, which will enable Solarvest to fund the CBD Research Project. In addition, Solarvest has appointed Dr. Edward J. Brennan, Jr., M.D., FACS (“Dr. Brennan”), currently the President of FSD Pharma’s BioSciences Division, to the board of directors of Solarvest.
Cartier Resources Inc. (TSX-V: ECR) (“Cartier”) has awarded InnovExplo the mandate to complete a resource estimate on the North and South Gold Corridors and a supporting NI 43 – 101 technical report for its 100% owned flagship Chimo Mine gold property located 45 kilometers east of Val-d’Or, Quebec.